Eric Eldering

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Venues

Leukemia

Oncogenesis

Blood advances

Cancer research communications

Academic Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Academic Medical Center

Netherlands

groupleader/professor :: Experimental Immunology

Publications

Jaco A C van Bruggen, Fleur S Peters, Morris Mes, Joanne M Rietveld, Elisa Cerretani, Gaspard Cretenet, Roel van Kampen, Aldo Jongejan, Perry D Moerland, Jan Joseph Melenhorst, Gerritje J W van der Windt, Eric Eldering, Arnon P Kater
T-cell dysfunction in CLL is mediated through expression of Siglec-10 ligands CD24 and CD52 on CLL cells. Blood advances 8 (17) (2024)
Jaco A C van Bruggen, Fleur S Peters, Morris Mes, Joanne M Rietveld, Elisa Cerretani, Gaspard Cretenet, Roel van Kampen, Aldo Jongejan, Perry D Moerland, Jan Joseph Melenhorst, Gerritje J W van der Windt, Eric Eldering, Arnon P Kater
T-cell dysfunction in CLL is mediated through expression of Siglec-10 ligands CD24 and CD52 on CLL cells. Blood advances 8 (17) (2024)
Jaco A C van Bruggen, Fleur S Peters, Morris Jorden Mes, Joanne M Rietveld, Elisa Cerretani, Gaspard Cretenet, Roel J W van Kampen, Aldo Jongejan, Perry D D Moerland, Jan Joseph Melenhorst, Eric Eldering, Arnon P Kater
T-cell dysfunction in CLL is mediated through expression of SIGLEC-10 ligands CD24 and CD52 on CLL cells. Blood advances (2024)
Francesca Favaro, Demi Both, Ingrid A M Derks, Marcel Spaargaren, Cristina Muñoz-Pinedo, Eric Eldering
Negligible role of TRAIL death receptors in cell death upon endoplasmic reticulum stress in B-cell malignancies. Oncogenesis 12 (1) (2023)
Francesca Favaro, Demi Both, Ingrid A M Derks, Marcel Spaargaren, Cristina Muñoz-Pinedo, Eric Eldering
Negligible role of TRAIL death receptors in cell death upon endoplasmic reticulum stress in B-cell malignancies. Oncogenesis 12 (1) (2023)
Karoline Kielbassa, Marco V Haselager, Danique J C Bax, Bianca F van Driel, Julie Dubois, Mark-David Levin, Sabina Kersting, Rebecka Svanberg, Carsten Utoft Niemann, Arnon P Kater, Eric Eldering
Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation. Leukemia (2023)
Francesca Favaro, Demi Both, Ingrid A M Derks, Marcel Spaargaren, Cristina Muñoz-Pinedo, Eric Eldering
Negligible role of TRAIL death receptors in cell death upon endoplasmic reticulum stress in B-cell malignancies. Oncogenesis 12 (1) (2023)
Anne W J Martens, Inga Kavazović, Mia Krapić, Su Min Pack, Ramon Arens, Aldo Jongejan, Perry D Moerland, Eric Eldering, Gerritje J W van der Windt, Felix M Wensveen, Fleur S Peters, Arnon P Kater
Chronic lymphocytic leukemia presence impairs antigen-specific CD8 + T-cell responses through epigenetic reprogramming towards short-lived effectors. Leukemia 37 (3) (2023)
Anne W J Martens, Inga Kavazović, Mia Krapić, Su Min Pack, Ramon Arens, Aldo Jongejan, Perry D Moerland, Eric Eldering, Gerritje J W van der Windt, Felix M Wensveen, Fleur S Peters, Arnon P Kater
Chronic lymphocytic leukemia presence impairs antigen-specific CD8 + T-cell responses through epigenetic reprogramming towards short-lived effectors. Leukemia (2023)
Francesca Favaro, Demi Both, Ingrid A M Derks, Marcel Spaargaren, Cristina Muñoz-Pinedo, Eric Eldering
Negligible role of TRAIL death receptors in cell death upon endoplasmic reticulum stress in B-cell malignancies. Oncogenesis 12 (1) (2023)
Anne W J Martens, Inga Kavazović, Mia Krapić, Su Min Pack, Ramon Arens, Aldo Jongejan, Perry D Moerland, Eric Eldering, Gerritje J W van der Windt, Felix M Wensveen, Fleur S Peters, Arnon P Kater
Chronic lymphocytic leukemia presence impairs antigen-specific CD8 + T-cell responses through epigenetic reprogramming towards short-lived effectors. Leukemia 37 (3) (2023)
Anne W J Martens, Inga Kavazović, Mia Krapić, Su Min Pack, Ramon Arens, Aldo Jongejan, Perry D Moerland, Eric Eldering, Gerritje J W van der Windt, Felix M Wensveen, Fleur S Peters, Arnon P Kater
Chronic lymphocytic leukemia presence impairs antigen-specific CD8 + T-cell responses through epigenetic reprogramming towards short-lived effectors. Leukemia (2023)
Chiara Montironi, Chaja Feige Jacobs, Gaspard Cretenet, Fleur S Peters, Bauke V Schomakers, Michel van Weeghel, Arnon P Kater, Helga Simon-Molas, Eric Eldering
T-cell dysfunction by pseudohypoxia and autocrine purinergic signaling in chronic lymphocytic leukemia. Blood advances (2023)
Anne W J Martens, Inga Kavazović, Mia Krapić, Su Min Pack, Ramon Arens, Aldo Jongejan, Perry D Moerland, Eric Eldering, Gerritje J W van der Windt, Felix M Wensveen, Fleur S Peters, Arnon P Kater
Chronic lymphocytic leukemia presence impairs antigen-specific CD8 + T-cell responses through epigenetic reprogramming towards short-lived effectors. Leukemia 37 (3) (2023)
Moritz Fürstenau, Yvonne J Thus, Sandra Robrecht, Clemens H M Mellink, Anne-Marie F van der Kevie-Kersemaekers, Julie Dubois, Julia von Tresckow, Michaela Patz, Michael Gregor, Patrick Thornton, Philipp Bernhard Staber, Tamar Tadmor, Mark-David Levin, Caspar da Cunha-Bang, Christof Schneider, Christian Bjørn Poulsen, Thomas Illmer, Björn Schöttker, Ann Janssens, Ilse Christiansen, Thomas Noesslinger, Michael Baumann, Holger Hebart, Tobias Gaska, Josien Regelink, Ellen C Dompeling, Vesa Lindstrom, Gunnar Juliusson, Anouk Andrea Widmer, Jeroen S Goede, Neta Goldschmidt, Florian Simon, Nisha De Silva, Anna Maria Fink, Kirsten Fischer, Clemens-Martin Wendtner, Matthias Ritgen, Monika Brüggemann, Eugen Tausch, Marcel Spaargaren, Eric Eldering, Stephan Stilgenbauer, Carsten Utoft Niemann, Michael Hallek, Barbara Eichhorst, Karl-Anton Kreuzer, Arnon P Kater
High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations. Blood (2023)
Marco V Haselager, Rachel Thijssen, Danique Bax, Demi Both, Francien De Boer, Simon Mackay, Julie Dubois, Clemens Mellink, Arnon P Kater, Eric Eldering
JAK-STAT signalling shapes the NF-κB response in CLL towards venetoclax sensitivity or resistance via Bcl-XL. Molecular oncology (2022)
Anne W J Martens, Joanne M Rietveld, Renate de Boer, Fleur S Peters, An Ngo, Lotte W H G van Mil, Koen de Heer, Marcel Spaargaren, Christie P M Verkleij, Niels W C J van de Donk, Homer C Adams, Eric Eldering, Carel J M van Noesel, Raluca I Verona, Arnon P Kater
Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas. Cancer research communications 2 (5) (2022)
Anne W J Martens, Joanne M Rietveld, Renate de Boer, Fleur S Peters, An Ngo, Lotte W H G van Mil, Koen de Heer, Marcel Spaargaren, Christie P M Verkleij, Niels W C J van de Donk, Homer C Adams, Eric Eldering, Carel J M van Noesel, Raluca I Verona, Arnon P Kater
Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas. Cancer research communications 2 (5) (2022)
Zhenghao Chen, Helga Simon-Molas, Gaspard Cretenet, Beatriz Valle-Argos, Lindsay D Smith, Francesco Forconi, Bauke V Schomakers, Michel van Weeghel, Dean J Bryant, Jaco A C van Bruggen, Fleur S Peters, Jeffrey C Rathmell, Gerritje J W van der Windt, Arnon P Kater, Graham Packham, Eric Eldering
Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment. Blood 140 (6) (2022)
Arnon P Kater, Jenny Qun Wu, Thomas J Kipps, Barbara Eichhorst, Peter Hillmen, James D'Rozario, Sarit E Assouline, Carolyn Owen, Tadeusz Robak, Javier de laSerna, Ulrich Jaeger, Guillaume Cartron, Marco Montillo, Julie Dubois, Eric Eldering, Clemens Mellink, Anne-Marie F van der Kevie-Kersemaekers, Su Young Kim, Brenda Chyla, Elizabeth Punnoose, Christopher R Bolen, Zoe June Assaf, Yanwen Jiang, Jue Wang, Marcus Lefebure, Michelle Boyer, Kathryn Humphrey, John Francis Seymour
Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (34) (2020)

Eric Eldering.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Eric Eldering